These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 26579374)
1. RasGAP-derived peptide GAP159 enhances cisplatin-induced cytotoxicity and apoptosis in HCT116 cells. Zhang H; Zhang S; He H; Zhang C; Chen Y; Yu D; Chen J; Shao R Acta Pharm Sin B; 2014 Apr; 4(2):128-34. PubMed ID: 26579374 [TBL] [Abstract][Full Text] [Related]
2. RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-κB in colon carcinoma HCT116 cells. Zhang H; Zhang S; He H; Zhao W; Ren K; Chen J; Shao RG Cancer Lett; 2011 Sep; 308(1):62-70. PubMed ID: 21570766 [TBL] [Abstract][Full Text] [Related]
3. TAT-RasGAP317-326-mediated tumor cell death sensitization can occur independently of Bax and Bak. Annibaldi A; Heulot M; Martinou JC; Widmann C Apoptosis; 2014 Apr; 19(4):719-33. PubMed ID: 24362790 [TBL] [Abstract][Full Text] [Related]
4. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition effect of peptide P110 plus cisplatin on various cancer cells and xenotransplanted tumors in mice. Li M; Wang J; Tan SY; Chen JH; Cui W; Chen ZQ; Zhang J Mol Med Rep; 2013 Apr; 7(4):1149-54. PubMed ID: 23447049 [TBL] [Abstract][Full Text] [Related]
6. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922 [TBL] [Abstract][Full Text] [Related]
7. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice. Michod D; Annibaldi A; Schaefer S; Dapples C; Rochat B; Widmann C J Natl Cancer Inst; 2009 Jun; 101(11):828-32. PubMed ID: 19470951 [TBL] [Abstract][Full Text] [Related]
8. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins. Michod D; Widmann C Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891 [TBL] [Abstract][Full Text] [Related]
10. A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells. Michod D; Yang JY; Chen J; Bonny C; Widmann C Oncogene; 2004 Nov; 23(55):8971-8. PubMed ID: 15467750 [TBL] [Abstract][Full Text] [Related]
11. MK2206 Enhances Cisplatin-Induced Cytotoxicity and Apoptosis in Testicular Cancer Through Akt Signaling Pathway Inhibition. Sun D; Wang J; Zhang H; Liu S; Wei P; Wang H; Xu Z; Fu Q; Zhang K Transl Oncol; 2020 Jul; 13(7):100769. PubMed ID: 32422572 [TBL] [Abstract][Full Text] [Related]
12. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB. Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284 [TBL] [Abstract][Full Text] [Related]
13. Synergistic cytotoxic effects of a combined treatment of a Zhang M; Yu Y; Zhang H; Huang H; Cai Q; Kang Y; Li G; Xu C Oncol Lett; 2017 Jun; 13(6):4748-4754. PubMed ID: 28588727 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. Chen HM; Lai ZQ; Liao HJ; Xie JH; Xian YF; Chen YL; Ip SP; Lin ZX; Su ZR Int J Mol Med; 2018 Mar; 41(3):1447-1454. PubMed ID: 29328398 [TBL] [Abstract][Full Text] [Related]
15. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo. Lin HH; Shi MD; Tseng HC; Chen JH Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380 [TBL] [Abstract][Full Text] [Related]
16. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells. Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190 [TBL] [Abstract][Full Text] [Related]
18. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study. Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669 [TBL] [Abstract][Full Text] [Related]
19. ART1 silencing enhances apoptosis of mouse CT26 cells via the PI3K/Akt/NF-κB pathway. Xiao M; Tang Y; Wang YL; Yang L; Li X; Kuang J; Song GL Cell Physiol Biochem; 2013; 32(6):1587-99. PubMed ID: 24335275 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer. Kosugi M; Miyajima A; Kikuchi E; Kosaka T; Horiguchi Y; Murai M; Oya M Urology; 2009 Mar; 73(3):655-60. PubMed ID: 19167032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]